{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:42:33Z","timestamp":1776922953159,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108763","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:02:46Z","timestamp":1752793366000},"page":"108763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and antitumor activity study of \u03b2-carboline derivatives as selective HDAC1\/2 inhibitors"],"prefix":"10.1016","volume":"163","author":[{"given":"Zhiya","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caizhi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hefeng","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangyao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bioorg.2025.108763_bb0005","first-page":"10","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Spring Harb Perspect Med."},{"issue":"7779","key":"10.1016\/j.bioorg.2025.108763_bb0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/d41586-019-03122-1","article-title":"Histone lactylation links metabolism and gene regulation","volume":"574","author":"Izzo","year":"2019","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.bioorg.2025.108763_bb0015","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2174\/0929867328666211108105214","article-title":"Histone modifications and their role in epigenetics of Cancer","volume":"29","author":"Zaib","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108763_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1369\/0022155413506582","article-title":"Histone deacetylases: a saga of perturbed acet- ylation homeostasis in cancer","volume":"62","author":"Parbin","year":"2014","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108763_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13148-021-01069-7","article-title":"Advances in epigenetic therapeutics with focus on solid tumors","volume":"13","author":"Jin","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"25","key":"10.1016\/j.bioorg.2025.108763_bb0030","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108763_bb0035","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108763_bb0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108763_bb0045","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1021\/acs.jmedchem.1c02179","article-title":"Optimization of class I histone deacetylase PROTACs reveals that HDAC1\/2 degradation is critical to induce apoptosis and cell arrest in Cancer cells","volume":"65","author":"Smalley","year":"2022","journal-title":"J. Med. Chem."},{"issue":"283","key":"10.1016\/j.bioorg.2025.108763_bb0050","article-title":"Synthetic approaches and clinical applications of representative HDAC inhibitors for cancer therapy: a review","volume":"5","author":"Lv","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108763_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010077","article-title":"HDAC inhibitor SAHA enhances antitumor immunity via the HDAC1\/JAK1\/FGL1 axis in lung adenocarcinoma","volume":"12","author":"Xu","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"285","key":"10.1016\/j.bioorg.2025.108763_bb0060","article-title":"Discovery of 4,5-dihydro-benzo[g]indazole-based hydroxamic acids as HDAC3\/BRD4 dual inhibitors and anti-tumor agents","volume":"5","author":"Li","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0065","doi-asserted-by":"crossref","first-page":"107284","DOI":"10.1016\/j.bioorg.2024.107284","article-title":"Discovery of novel benzimidazole derivatives as potent HDACs inhibitors against leukemia with (Thio)Hydantoin as zinc-binding moiety: design, synthesis, enzyme inhibition, and cellular mechanistic study","volume":"146","author":"Gaber Abdulwahaba","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"227","key":"10.1016\/j.bioorg.2025.108763_bb0070","article-title":"Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)","volume":"5","author":"He","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108763_bb0075","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1021\/acs.jmedchem.5b01052","article-title":"Novel b-carboline\/hydroxamic acid hybrids targeting both histone deacetylase and DNA display high anticancer activity via regulation of the p53 signaling pathway","volume":"58","author":"Ling","year":"2015","journal-title":"J. Med. Chem."},{"issue":"97","key":"10.1016\/j.bioorg.2025.108763_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejmech.2014.11.031","article-title":"Bioactive heterocycles containing endocyclic N-hydroxy groups","volume":"5","author":"Rani","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"269","key":"10.1016\/j.bioorg.2025.108763_bb0085","article-title":"Discovery of novel itaconimide-based derivatives as potent HDAC inhibitors for the efficient treatment of prostate cancer","volume":"5","author":"Jiang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108763_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127638","article-title":"Discovery of thiosemicarbazone-containing compounds with potent anti- proliferation activity against drug-resistant K562\/A02 cells","volume":"30","author":"Gu","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108763_bb0095","doi-asserted-by":"crossref","first-page":"16573","DOI":"10.1021\/acs.jmedchem.1c01155","article-title":"Structure-based design of dual-acting compounds targeting adenosine a(2A) receptor and histone deacetylase as novel tumor immunotherapeutic agents","volume":"64","author":"Yan","year":"2021","journal-title":"J. Med. Chem."},{"issue":"209","key":"10.1016\/j.bioorg.2025.108763_bb0100","article-title":"Paradigm shift of \u201cclassical\u201d HDAC inhibitors to \u201chybrid\u201d HDAC inhibitors in therapeutic interventions","volume":"1","author":"Vaidya","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108763_bb0105","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1078-0432.CCR-14-1290","article-title":"Selective inhibition of HDAC1 and HDAC2 as a potential therapeutic option for B-ALL","volume":"21","author":"Stubbs","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108763_bb0110","doi-asserted-by":"crossref","first-page":"46645","DOI":"10.1038\/srep46645","article-title":"Selective targeting of HDAC1\/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH medulloblastoma","volume":"9","author":"Coni","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108763_bb0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.chembiol.2013.03.020","article-title":"Selective HDAC1\/HDAC2 inhibitors induce neuroblastoma differentiation","volume":"20","author":"Frumm","year":"2013","journal-title":"Chem. Biol."},{"issue":"28","key":"10.1016\/j.bioorg.2025.108763_bb0120","doi-asserted-by":"crossref","first-page":"12617","DOI":"10.1073\/pnas.1006774107","article-title":"Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease","volume":"107","author":"Bradner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"157","key":"10.1016\/j.bioorg.2025.108763_bb0125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ejmech.2018.08.027","article-title":"\u03b2-Carboline alkaloid monomers and dimers: occurrence, structural diversity, and biological activities","volume":"5","author":"Dai","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0130","doi-asserted-by":"crossref","unstructured":"D. Li, W. Liu, Y. Huang, M. Liu, C. Tian, H. Lu, H. Jia, Z. Xu, H. Ding, Q. Zhao, Facile synthesis of C1-substituted \u03b2-carbolines as CDK4 inhibitors for the treatment of cancer, Bioorg. Chem. 121(0) (2022) 105659, doi:https:\/\/doi.org\/10.1016\/j.bioorg.2022.105659.","DOI":"10.1016\/j.bioorg.2022.105659"},{"issue":"64","key":"10.1016\/j.bioorg.2025.108763_bb0135","article-title":"Design, synthesis, and biological evaluation of \u03b2-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects","volume":"15","author":"Tian","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108763_bb0140","doi-asserted-by":"crossref","unstructured":"R. Tokala, S. Mahajan, G. Kiranmai, D. K. Sigalapalli, S. Sana, S. E. John, N. Nagesh, N. Shankaraiah, Development of \u03b2-carboline-benzothiazole hybrids via carboxamide formation as cytotoxic agents: DNA intercalative topoisomerase II\u03b1 inhibition and apoptosis induction, Bioorg. Chem. 106 (0) (2021) 104481, doi:https:\/\/doi.org\/10.1016\/j.bioorg.2020.104481.","DOI":"10.1016\/j.bioorg.2020.104481"},{"key":"10.1016\/j.bioorg.2025.108763_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113321","article-title":"\u0392-Carbolines as potential anticancer agents","volume":"216","author":"Aaghaz","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0150","doi-asserted-by":"crossref","unstructured":"H. K. Namballa, P. Anchi, K. Lakshmi Manasa, J. P. Soni, C. Godugu, N. Shankaraiah, A. Kamal, \u03b2-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies, Bioorg. Chem. 117 (0) (2021) 105461, doi:https:\/\/doi.org\/10.1016\/j.bioorg.2021.105461.","DOI":"10.1016\/j.bioorg.2021.105461"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108763_bb0155","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-140066","article-title":"Tubastatin a\/ACY-1215 improves cognition in Alzheimer's disease transgenic mice","volume":"41","author":"Zhang","year":"2014","journal-title":"J Alzheimer's Dis"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108763_bb0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/jm200773h","article-title":"Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells","volume":"55","author":"Kalin","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0165","doi-asserted-by":"crossref","unstructured":"R. Cao, Chen, Q. Hou, H. Chen, H. Guan, Y. Ma, W. Peng, A. Xu, Synthesis, acute toxicities, and antitumor effects of novel 9-substituted beta-carboline derivatives, Bioorgan. Med. Chem. 12(17) (2004) 4613, doi:https:\/\/doi.org\/10.1016\/j.bmc.2004.06.038.","DOI":"10.1016\/j.bmc.2004.06.038"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108763_bb0170","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3892\/ijo.2013.2069","article-title":"The novel synthetic compound 6-acetyl-9-(3,4,5-trimetho-xybenzyl)-9H-pyrido[2,3-b]indole induces mitotic arrest and apoptosis in human COLO 205 cells","volume":"43","author":"Lin","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108763_bb0175","doi-asserted-by":"crossref","first-page":"11262","DOI":"10.1038\/ncomms11262","article-title":"Insights into the activation mechanism of class I HDAC complexes by inositol phosphates","volume":"25","author":"Watson","year":"2016","journal-title":"Nat. Commun."},{"issue":"37","key":"10.1016\/j.bioorg.2025.108763_bb0180","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108763_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/prot.10250","article-title":"Efficient RMSD measures for the comparison of two molecular ensembles. root-mean-square deviation","volume":"50","author":"Br\u00fcschweiler","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.bioorg.2025.108763_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2022.11.017","article-title":"De novo design of dual-target JAK2, SMO inhibitors based on deep reinforcement learning, molecular docking and molecular dynamics simulations","volume":"638","author":"He","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108763_bb0195","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration is indicator of compactness of protein structure","volume":"42","author":"Lobanov","year":"2008","journal-title":"Mol. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108763_bb0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00894-018-3695-7","article-title":"Investigation of the effect of homocysteinylation of substance P on its binding to the NK1 receptor using molecular dynamics simulation","volume":"24","author":"Davoudmanesh","year":"2018","journal-title":"J. Mol. Model."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108763_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-2836(84)90231-6","article-title":"Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect","volume":"178","author":"Richmond","year":"1984","journal-title":"J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108763_bb0210","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1080\/07391102.2022.2036240","article-title":"In silico evaluation of binding of phytochemicals from bayati (Anamirta cocculus Linn) to the glutathione-s-transferase of Asian corn borer (Ostrinia furnacalis Guen\u00e9e)","volume":"41","author":"Castrosanto","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108763_bb0215","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1021\/j100854a047","article-title":"Electric conductance and pH measurements of isoionic salt-free bovine mercaptalbumin solutions. An evaluation of root-mean-square proton fluctuations","volume":"72","author":"Baskin","year":"1968","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.134048","article-title":"Comparison on inhibitory effect and mechanism of inhibitors on sPPO and mPPO purified from \u201cLijiang snow\u201d peach by combining multispectroscopic analysis, molecular docking and molecular dynamics simulation","volume":"400","author":"Zhou","year":"2023","journal-title":"Food Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108763_bb0225","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1021\/acs.jcim.9b01134","article-title":"Deciphering the inhibition mechanism of under trial Hsp90 inhibitors and their analogues: a comparative molecular dynamics simulation","volume":"60","author":"Nazar","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"204","key":"10.1016\/j.bioorg.2025.108763_bb0230","article-title":"Identification of novel potent and non-toxic anticancer, anti-angiogenic and antimetastatic rhenium complexes against colorectal carcinoma","volume":"15","author":"Delasoie","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"352","key":"10.1016\/j.bioorg.2025.108763_bb0235","article-title":"A novel HDAC1\/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation","volume":"25","author":"Lee","year":"2022","journal-title":"Chemico-Biol. Interact."},{"issue":"215","key":"10.1016\/j.bioorg.2025.108763_bb0240","doi-asserted-by":"crossref","first-page":"113169","DOI":"10.1016\/j.ejmech.2021.113169","article-title":"CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition","volume":"5","author":"Singh","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108763_bb0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/cddis.2013.61","article-title":"Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression","volume":"4","author":"Sachweh","year":"2013","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108763_bb0250","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/jcp.25467","article-title":"HDAC1, HDAC4, and HDAC9 bind to PC3\/Tis21\/Btg2 and are required for its inhibition of cell cycle progression and cyclin D1 expression","volume":"232","author":"Micheli","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioorg.2025.108763_bb0255","doi-asserted-by":"crossref","unstructured":"R. Sangwan, R. Rajan, P.K. Mandal, HDAC as onco target: reviewing the synthetic approaches with SAR study of their inhibitors, Eur. J. Med. Chem. 158(0) (2018) 620\u2013706, https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.073.","DOI":"10.1016\/j.ejmech.2018.08.073"},{"key":"10.1016\/j.bioorg.2025.108763_bb0260","doi-asserted-by":"crossref","unstructured":"L. Chen, Y. Zhang, J. Liu, W. Wang, X. Li, L. Zhao, W. Wang, B. Li, Novel 4-ar- ylaminoquinazoline derivatives with (E)-propen-1-yl moiety as potent EGFR in- hibitors with enhanced antiproliferative activities against tumor cells, Eur. J. Med. Chem. 138(0) (2017) 689\u2013697, http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ejmech.2017.06.023.","DOI":"10.1016\/j.ejmech.2017.06.023"},{"key":"10.1016\/j.bioorg.2025.108763_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113554","article-title":"Design, synthesis and biological evaluation of harmine derivatives as potent GSK- 3\u03b2\/DYRK1A dual inhibitors for the treatment of Alzheimer's disease","volume":"222","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116765","article-title":"Isoalantolactone\/hydroxamic acid hybrids as potent dual STAT3\/HDAC inhibitors and self-assembled nanoparticles for cancer therapy","volume":"277","author":"Mo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0275","doi-asserted-by":"crossref","unstructured":"L. Zhou, Z. Qi, X. Wang, Z. Li, W. Feng, N. Wang, X. Li, X. Ning, Y. Xing, X. Jiang, etal., Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3, Eur. J. Med. Chem. 276 (2024) 116729, https:\/\/doi.org\/10.1016\/j.ejmech.2024.116729.","DOI":"10.1016\/j.ejmech.2024.116729"},{"key":"10.1016\/j.bioorg.2025.108763_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112291","article-title":"Pu- rine\/purine isostere based scaffolds as new derivatives of benzamide class of HDAC inhibitors","volume":"196","author":"Nepali","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108763_bb0285","doi-asserted-by":"crossref","unstructured":"H. Geng, F. Zheng, W. Sun, S. Huang, Z. Wang, K. Yang, C. Wang, C. Tian, C. Xu, G. Zhai, M. Zhao, S. Hou, A. Song, Y. Zhang, Q. Zhao, Effect and mechanism of novel HDAC inhibitor ZDLT-1 in colorectal Cancer by regulating apoptosis and inflammation, Int. Immunopharmacol. 143(0) (2024) 113333, doi:https:\/\/doi.org\/10.1016\/j.intimp.2024.113333.","DOI":"10.1016\/j.intimp.2024.113333"},{"key":"10.1016\/j.bioorg.2025.108763_bb0290","doi-asserted-by":"crossref","unstructured":"L. Wu, W. Liu, Y. Huang, C. Zhu, Q. Ma, Q. Wu, L. Tian, X. Feng, M. Liu, N. Wang, et al., Development and structure-activity relationship of tacrine derivatives as highly potent CDK2\/9 inhibitors for the treatment of cancer, Eur. J. Med. Chem. 242(0) (2022) 114701, https:\/\/doi.org\/10.1016\/j.ejmech.2022.114701.","DOI":"10.1016\/j.ejmech.2022.114701"},{"key":"10.1016\/j.bioorg.2025.108763_bb0295","doi-asserted-by":"crossref","unstructured":"H. Hu, F. Chen, Y. Dong, Y. Liu, P. Gong, Discovery of novel dual c-met\/HDAC inhibitors as a promising strategy for Cancer therapy, Bioorg. Chem. 101(0) (2020) 103970, doi:https:\/\/doi.org\/10.1016\/j.bioorg.2020.103970.","DOI":"10.1016\/j.bioorg.2020.103970"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:55:55Z","timestamp":1776920155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":59,"alternative-id":["S0045206825006431"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108763","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antitumor activity study of \u03b2-carboline derivatives as selective HDAC1\/2 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108763"}}